Predictions
NAGA Group
Start price
Target price
Perf. (%)
€6.15
06.02.21
06.02.21
-
06.02.22
06.02.22
14.63%
11.03.21
11.03.21
Could be very worthwhile Investment >20% year
STS Group AG
Start price
Target price
Perf. (%)
€6.98
23.01.21
23.01.21
-
23.01.22
23.01.22
16.33%
24.01.22
24.01.22
Medium risks for its business
Some uniques
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Westwing Group AG
Start price
Target price
Perf. (%)
€31.42
25.12.20
25.12.20
€48.60
25.12.21
25.12.21
-29.59%
26.12.21
26.12.21
Could be worthwhile Investment >10% per year
Knorr-Bremse AG
Start price
Target price
Perf. (%)
€107.68
30.11.20
30.11.20
-
29.11.23
29.11.23
-18.44%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
STS Group AG
Start price
Target price
Perf. (%)
€4.82
27.11.20
27.11.20
-
-5.39%
11.12.20
11.12.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
STS Group AG
Start price
Target price
Perf. (%)
€4.61
27.11.20
27.11.20
€5.00
4.56%
27.11.20
27.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
STS Group AG
Start price
Target price
Perf. (%)
€4.56
25.11.20
25.11.20
€5.00
1.10%
27.11.20
27.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Dermapharm Holding SE
Start price
Target price
Perf. (%)
€54.09
24.11.20
24.11.20
€59.00
24.11.21
24.11.21
28.86%
06.08.21
06.08.21
Knorr-Bremse AG
Start price
Target price
Perf. (%)
€105.04
19.11.20
19.11.20
€108.00
19.11.21
19.11.21
-11.69%
20.11.21
20.11.21
Could be worthwhile Investment >10% per year
STS Group AG
Start price
Target price
Perf. (%)
€3.07
21.10.20
21.10.20
€3.00
04.11.21
04.11.21
3.26%
10.11.20
10.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected